Stopping prereferral rectal artesunate - a grave error
BMJ Glob Health
.
2022 Jul;7(7):e010006.
doi: 10.1136/bmjgh-2022-010006.
Authors
James A Watson
1
2
,
Marian Warsame
3
,
Thomas J Peto
1
,
Marie Onyamboko
4
5
,
Caterina Fanello
2
4
,
Arjen M Dondorp
1
2
,
Nicholas White
6
2
Affiliations
1
Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
2
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
3
School of Public Health and Community Medicine, University of Gothenburg, Gothenburg, Sweden.
4
Kinshasa Oxford Medical Research Unit, Kinshasa, Democratic Republic of Congo.
5
Kinshasa School of Public Health, University of Kinshasa Faculty of Medicine, Kinshasa, Congo (the Democratic Republic of the).
6
Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand nickw@tropmedres.ac.
PMID:
35831037
PMCID:
PMC9280904
DOI:
10.1136/bmjgh-2022-010006
No abstract available
Keywords:
malaria.
MeSH terms
Antimalarials* / therapeutic use
Artesunate / therapeutic use
Humans
Malaria*
Referral and Consultation
Substances
Antimalarials
Artesunate